首頁 > 市場調查報告書 > 材料/化學品

有機化合物

市場調查報告書

商品編碼

1779230

二甲基甲醯胺市場－全球產業規模、佔有率、趨勢、機會和預測，按類型（反應物、原料）、按最終用戶（化學、電子、製藥、農業）、按地區和競爭細分，2020-2030 年

Dimethylformamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Reactant, Feedstock), By End User (Chemical, Electronics, Pharmaceutical, Agriculture), By Region and Competition, 2020-2030F

出版日期: 2025年07月29日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球二甲基甲醯胺市場價值為 25.3 億美元，預計到 2030 年將達到 29.7 億美元，複合年成長率為 2.84%。二甲基甲醯胺 (DMF) 是一種廣泛使用的無色有機溶劑，以其在工業和化學應用中的多功能性而聞名。 DMF 的化學表示為 (CH3)2NC(O)H，是一種親水性非質子溶劑，沸點高，使其成為促進 SN2 機制等極性反應的理想選擇。它與水和各種有機化合物結合時會形成均相混合物，因此廣泛應用於化學合成。 DMF 主要由甲酸和二甲胺反應生成。然而，它在強酸或強鹼中化學不穩定，會水解成甲酸和二甲胺。由於其高水溶性、有機性質和緩慢的蒸發速度，DMF 仍然是多個工業領域的首選溶劑。

市場概覽
預測期	2026-2030
2024年市場規模	25.3億美元
2030年市場規模	29.7億美元
2025-2030 年複合年成長率	2.84%
成長最快的領域	反應物
最大的市場	亞太地區

儘管DMF在工業上具有重要意義，但它也帶來了嚴重的健康和安全隱患，影響著市場動態。研究表明，接觸DMF可能導致潛在的致癌作用和疑似先天性殘疾，這導致某些地區推出了監管限制，尤其限制了女性在接觸DMF的工作場所的接觸。雖然國際癌症研究機構（IARC）將DMF歸類為潛在致癌物，但美國環保署（EPA）並不認為有明確的致癌風險。然而，根據EPA報告，急性暴露於DMF可能導致嚴重的健康問題，包括肝衰竭，這對其市場接受度和成長構成了嚴峻挑戰。因此，許多行業正在轉向更安全的替代品，例如二甲基亞碸（DMSO），以降低健康風險。

關鍵市場促進因素

製藥業對二甲基甲醯胺的需求不斷成長

主要市場挑戰

原料成本波動

主要市場趨勢

高純度DMF的需求不斷成長

Global Dimethylformamide Market was valued at USD 2.53 Billion in 2024 and is expected to reach USD 2.97 Billion by 2030 with a CAGR of 2.84%. Dimethylformamide (DMF) is a widely used, colorless organic solvent known for its versatility in industrial and chemical applications. Chemically represented as (CH3)2NC(O)H, DMF serves as a hydrophilic aprotic solvent with a high boiling point, making it ideal for facilitating polar reactions such as SN2 mechanisms. It forms homogeneous mixtures when combined with water and various organic compounds, contributing to its widespread use in chemical synthesis. DMF is primarily produced through the reaction of formic acid and dimethylamine. However, it is chemically unstable when exposed to strong acids or bases, undergoing hydrolysis into formic acid and dimethylamine. Due to its high water solubility, organic nature, and slow evaporation rate, DMF remains a preferred solvent across multiple industrial sectors.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.53 Billion
Market Size 2030	USD 2.97 Billion
CAGR 2025-2030	2.84%
Fastest Growing Segment	Reactant
Largest Market	Asia Pacific

Despite its industrial importance, DMF poses significant health and safety concerns that affect market dynamics. Research has linked DMF exposure to potential carcinogenic effects and suspected congenital disabilities, leading to regulatory restrictions in certain regions, particularly limiting women's exposure in workplaces handling DMF. While the International Agency for Research on Cancer (IARC) classifies DMF as a possible carcinogen, the U.S. Environmental Protection Agency (EPA) does not consider it a definitive cancer risk. Nonetheless, acute exposure to DMF can cause severe health issues, including liver failure, as reported by the EPA, which represents a critical challenge to its market acceptance and growth. Consequently, many industries are shifting toward safer alternatives, such as dimethyl sulfoxide (DMSO), to mitigate health risks.

Key Market Drivers

Growing Demand of Dimethylformamide from Pharmaceutical Industry

Dimethylformamide (DMF) is a critical organic solvent extensively used in the pharmaceutical industry, playing a vital role in the manufacturing of various drugs, including antibiotics, antivirals, and pharmaceutical adjuvants. Its widespread adoption stems from its superior solvent capabilities, excellent chemical stability, and low evaporation rate, making it essential in numerous drug production processes. India's pharmaceutical industry, valued at approximately USD 58 billion currently, is expected to expand significantly, reaching USD 125 billion by 2030 and USD 425 billion by 2047. This rapid growth in the pharmaceutical sector is a key driver for the dimethylformamide (DMF) market, as DMF is widely used as a critical solvent in drug manufacturing. The industry's expansion will increase demand for DMF, supporting its market growth and encouraging further innovation and production to meet evolving pharmaceutical needs.

The pharmaceutical sector's rapid growth, driven by global health challenges and increased drug demand, has significantly boosted the market for DMF. This rising demand has prompted manufacturers to focus on enhancing the quality and efficiency of DMF to better meet the evolving requirements of pharmaceutical production. Beyond its traditional applications, DMF is increasingly utilized in innovative pharmaceutical technologies, such as advanced drug delivery systems, expanding its scope and value within the industry. This diversification underscores DMF's adaptability and its critical contribution to pharmaceutical innovation.

As the global pharmaceutical market continues to expand, propelled by the development of new drugs and cutting-edge delivery methods, the demand for DMF is projected to grow correspondingly. Manufacturers are expected to invest further in research and development to improve DMF formulations, ensuring compliance with stringent quality standards and supporting the pharmaceutical industry's dynamic needs. The pharmaceutical industry represents a key growth driver for the global DMF market. The sector's ongoing expansion and innovation are expected to sustain and accelerate demand for DMF, reinforcing its strategic importance. As pharmaceutical companies continue to develop novel therapies and delivery platforms, DMF will remain an indispensable solvent, underpinning the future growth and evolution of the global DMF market.

Key Market Challenges

Volatility in Cost of Raw Materials

DMF (Dimethylformamide) is a versatile organic compound extensively used as a solvent in various industries, including pharmaceuticals, agriculture, and chemical production. Its widespread application stems from its excellent solvency properties and compatibility with different substances. However, the production of DMF is not without its complexities.

The manufacturing process of DMF involves the utilization of several raw materials, each of which contributes to the overall cost of production. These raw materials are subject to market dynamics and can experience fluctuations due to various factors, such as supply disruptions, demand spikes, and trade restrictions. The volatility in raw material prices adds an additional layer of complexity to the DMF market.

In recent times, the DMF market has witnessed a sustained decline in price trends. This downward trajectory can be partly attributed to the weak methanol prices and a steady demand from downstream industries. While this may seem beneficial for manufacturers in the short term, it introduces a level of unpredictability that can make long-term planning and investment decisions challenging.

Fluctuating raw material costs can significantly impact manufacturers' profit margins. When these costs rise, manufacturers are faced with a difficult choice - either absorb the increased costs, resulting in reduced profits, or pass them onto customers, potentially leading to a decrease in demand. Such market dynamics can create a delicate balance for manufacturers to maintain their competitiveness while ensuring sustainable profitability.

Key Market Trends

Growing Demand of High-Purity DMF

High-purity DMF, a refined version of the organic compound, is extensively used as a solvent and reagent in the pharmaceutical industry. Its exceptional properties, including high solvent power, excellent chemical stability, and low evaporation rate, make it a vital component in the manufacture of various drugs. From antibiotics to antiviral medications and pharmaceutical adjuvants, high-purity DMF plays a crucial role in ensuring the purity and efficacy of these pharmaceutical products.

The pharmaceutical sector's preference for high-purity DMF stems from its ability to maintain strict purity levels, preventing contamination that could compromise the quality of drugs. As the demand for pharmaceuticals surges, especially in the face of the ongoing global health crisis, the need for high-purity DMF has significantly increased. This growing demand is driving the growth of the DMF market, as manufacturers strive to meet the requirements of the expanding pharmaceutical industry.

The growing demand for high-purity dimethylformamide from the pharmaceutical industry represents a major trend in the global DMF market. As the pharmaceutical sector continues to expand and evolve, this trend is expected to play an even more significant role in shaping the future of the DMF market. The critical role of high-purity DMF in drug manufacturing processes underscores its importance in ensuring the safety and efficacy of pharmaceutical products, making it an indispensable component in the pharmaceutical industry's pursuit of innovation and excellence.

Key Market Players

BASF SE
Balaji Amines Ltd.
Bell Chem Corp
Methanol Chemicals Co.
Eastman Chemical Company
Jiutian Chemical Group Ltd.
Luxi Group Co Ltd
Mitsubishi Gas Chemical Company Inc.
PON Pure Chemical India Pvt Ltd
Shandong Hualu-Hengsheng Chemical Co., Ltd.

Report Scope:

In this report, the Global Dimethylformamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dimethylformamide Market, By Type:

Reactant
Feedstock

Dimethylformamide Market, By End User:

Chemical
Electronics
Pharmaceutical
Agriculture

Dimethylformamide Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dimethylformamide Market.

Available Customizations:

Global Dimethylformamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Dimethylformamide Market Outlook

4.1. Market Size & Forecast
- 4.1.1. By Value & Volume
4.2. Market Share & Forecast
- 4.2.1. By Type (Reactant, Feedstock)
- 4.2.2. By End User (Chemical, Electronics, Pharmaceutical, Agriculture)
- 4.2.3. By Region
- 4.2.4. By Company (2024)
4.3. Market Map
- 4.3.1. By Type
- 4.3.2. By End User
- 4.3.3. By Region

5. Asia Pacific Dimethylformamide Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value & Volume
5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By End User
- 5.2.3. By Country
5.3. Asia Pacific: Country Analysis
- 5.3.1. China Dimethylformamide Market Outlook
  - 5.3.1.1. Market Size & Forecast
    - 5.3.1.1.1. By Value & Volume
  - 5.3.1.2. Market Share & Forecast
    - 5.3.1.2.1. By Type
    - 5.3.1.2.2. By End User
- 5.3.2. India Dimethylformamide Market Outlook
  - 5.3.2.1. Market Size & Forecast
    - 5.3.2.1.1. By Value & Volume
  - 5.3.2.2. Market Share & Forecast
    - 5.3.2.2.1. By Type
    - 5.3.2.2.2. By End User
- 5.3.3. Australia Dimethylformamide Market Outlook
  - 5.3.3.1. Market Size & Forecast
    - 5.3.3.1.1. By Value & Volume
  - 5.3.3.2. Market Share & Forecast
    - 5.3.3.2.1. By Type
    - 5.3.3.2.2. By End User
- 5.3.4. Japan Dimethylformamide Market Outlook
  - 5.3.4.1. Market Size & Forecast
    - 5.3.4.1.1. By Value & Volume
  - 5.3.4.2. Market Share & Forecast
    - 5.3.4.2.1. By Type
    - 5.3.4.2.2. By End User
- 5.3.5. South Korea Dimethylformamide Market Outlook
  - 5.3.5.1. Market Size & Forecast
    - 5.3.5.1.1. By Value & Volume
  - 5.3.5.2. Market Share & Forecast
    - 5.3.5.2.1. By Type
    - 5.3.5.2.2. By End User

6. Europe Dimethylformamide Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value & Volume
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End User
- 6.2.3. By Country
6.3. Europe: Country Analysis
- 6.3.1. France Dimethylformamide Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value & Volume
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By End User
- 6.3.2. Germany Dimethylformamide Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value & Volume
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By End User
- 6.3.3. Spain Dimethylformamide Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value & Volume
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By End User
- 6.3.4. Italy Dimethylformamide Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value & Volume
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Type
    - 6.3.4.2.2. By End User
- 6.3.5. United Kingdom Dimethylformamide Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value & Volume
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Type
    - 6.3.5.2.2. By End User

7. North America Dimethylformamide Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value & Volume
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End User
- 7.2.3. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Dimethylformamide Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value & Volume
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By End User
- 7.3.2. Mexico Dimethylformamide Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value & Volume
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By End User
- 7.3.3. Canada Dimethylformamide Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value & Volume
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By End User

8. South America Dimethylformamide Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value & Volume
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End User
- 8.2.3. By Country
8.3. South America: Country Analysis
- 8.3.1. Brazil Dimethylformamide Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value & Volume
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By End User
- 8.3.2. Argentina Dimethylformamide Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value & Volume
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By End User
- 8.3.3. Colombia Dimethylformamide Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value & Volume
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By End User

9. Middle East and Africa Dimethylformamide Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value & Volume
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End User
- 9.2.3. By Country
9.3. MEA: Country Analysis
- 9.3.1. South Africa Dimethylformamide Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value & Volume
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By End User
- 9.3.2. Saudi Arabia Dimethylformamide Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value & Volume
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By End User
- 9.3.3. UAE Dimethylformamide Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value & Volume
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By End User
- 9.3.4. Egypt Dimethylformamide Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value & Volume
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Type
    - 9.3.4.2.2. By End User

10. Market Dynamics

10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Dimethylformamide Market: SWOT Analysis

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape

14.1. BASF SE
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Current Capacity Analysis
- 14.1.5. Financials (In case of listed)
- 14.1.6. Recent Developments
- 14.1.7. SWOT Analysis
14.2. Balaji Amines Ltd.
14.3. Bell Chem Corp
14.4. Methanol Chemicals Co.
14.5. Eastman Chemical Company
14.6. Jiutian Chemical Group Ltd.
14.7. Luxi Group Co Ltd
14.8. Mitsubishi Gas Chemical Company Inc.
14.9. PON Pure Chemical India Pvt Ltd
14.10. Shandong Hualu-Hengsheng Chemical Co., Ltd.